![]() |
|
|
Division of Endocrinology and Metabolism, National Institute of Nutrition, Hyderabad 500 007 India
2To whom correspondence should be addressed. E-mail: manchalar{at}yahoo.com.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: body fat glucose tolerance insulin resistance magnesium maternal undernutrition
Intrauterine growth retardation has been linked to the development of diseases such as hypertension, type 2 diabetes, and obesity in later life (1,2). Insulin resistance (IR)3 is the common underlying feature, but its causes are not clear. Epidemiologic data and studies in experimental animals suggest that fetal and early postnatal nutritional adaptations persist and are expressed in adulthood, even in the absence of the stimulus or stress that initiated them (3). Termed "metabolic programming," this has important implications for adult-onset diseases and abundant evidence demonstrates that the quantity and quality of nutrition during critical periods of early development influence the organisms susceptibility to adult-onset pathological conditions (46). However, most studies have considered only maternal macronutrient deficiency (7,8). Recently, maternal iron restriction was reported to cause hypertension and alter lipid metabolism in rat pups (9). We observed recently that maternal mineral restriction altered the body fat content, plasma lipids, and oxidative stress in rat pups and may thus predispose them to IR in later life (10). However, the causative mineral(s) or their role in this process is not yet known.
Magnesium, the 4th most common cation in the body, affects numerous biological processes by modulating cell cycle progression, differentiation, and proliferation (11). As a cofactor of several enzymes, it modulates energy metabolism, carbohydrate oxidation, and glucose transport across the cell membrane (12,13). Mg also regulates insulin at levels such as secretion, receptor- binding, and activity (14,15).
Intestinal absorption and cellular distribution are among the factors important in maintaining intra- and extracellular Mg concentrations (16). Intracellular Mg concentration and transport are correlated with insulin-mediated glucose uptake (17,18). Indeed, intracellular accumulation of Mg depends upon insulin action, and subclinical Mg deficiency is common in people with diabetes and cardiovascular disorders (12,19). Alternatively, intracellular Mg deficiency could be due to IR, and it is also suggested that Mg deficiency may worsen IR (16,20). Interestingly, intracellular Mg concentrations are lower in hypertensive people, and Mg depletion from cells of normotensive people was reported to render them insulin resistant (21).
Data on the prevalence of Mg deficiency are scarce. The incidence is reported to be 2539% in patients with diabetes mellitus (22) and
45% in pregnant women of developing countries such as India (23). Despite this and the known effects of Mg on insulin secretion and action, the role of maternal Mg deficiency in predisposing the pups to IR has not been assessed. In light of our earlier studies (10), we hypothesized that maternal Mg restriction predisposes the pups to IR in later life. The present study was carried out in Wistar/NIN (WNIN) rats to validate or negate this hypothesis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Animals: feeding, maintenance and breeding. Female weanling WNIN rats (n = 28) were obtained from National Centre for Laboratory Animal Sciences, National Institute of Nutrition. They were divided into 2 groups of 7 and 21, housed individually in polypropylene cages with wire mesh bottoms and maintained at 22 ± 2°C, under standard lighting conditions (12-h light:dark cycle). The group of 21 rats consumed ad libitum for 9 wk the AIN-93G diet (24) containing 165 mg Mg/kg diet (Mg restricted: R), and the group of 7 rats was pair-fed (offered the mean intake of the R group) the control AIN-93 G diet (C) containing 650 mg Mg/kg diet. All rats had free access to deionized water. After 9 wk of feeding, the hemoglobin level and the concentrations of Mg, glucose, insulin, cholesterol, and triglycerides were determined in blood plasma.
The rats were mated with control males (2 females to 1 male), and the pregnant rats continued to consume their respective diets throughout gestation. The control dams and their pups consumed the control diet throughout (C). At parturition, 7 of the 21 R dams were switched to the control diet (RP), and the others consumed a restricted diet during lactation. In all groups, a uniform litter size of 8 pups/dam (equal number of male and females) was maintained from postnatal d 3, until weaning on postnatal d 21. C and RP pups were weaned onto the control diet, whereas some R pups were weaned onto control diet (RW) and some continued to be Mg restricted (R).
From weaning, 8 male pups from 45 dams of the corresponding group were maintained in each group and they consumed their respective diets and deionized water ad libitum until postnatal d 180. To avoid the possible effects of estrous cycle on glucose and fat metabolism and IR, only male pups were included in this study. Figure 1 gives the schematic representation of the feeding protocol used. Food intake (daily) and body weights (once a week) were recorded in dams and pups.
|
Glucose tolerance test. An i.p. glucose tolerance test (IPGTT) was performed on 8 pups of each of the groups on postnatal d 90 and 180. Briefly, after overnight food deprivation (16 h), glucose (250 g/L) was administered i.p. as a bolus, at a dose of 1 g/kg body weight, and blood samples were collected at 0, 15, 30, 60, and 120 min for determining plasma glucose and insulin concentrations. Glucose and insulin responses during the glucose-tolerance test were computed from the area under the curve (AUC) for glucose and insulin, respectively, using the trapezoidal method (26).
Indices of insulin resistance. Indices based on fasting glucose and insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and one that takes into account the pups response to a challenge with glucose (ratio of glucose AUC: insulin AUC) were computed as described previously (10).
Body composition. Body composition of the pups was determined on d 90 and 180 using the total body electrical conductivity (TOBEC) small animal body composition analysis system (EM-SCAN, Model SA-3000 Multi detector) (27). Lean body mass (LBM), the percentage of body fat, and fat-free mass (FFM) were computed mathematically according to Morbach et al. (28) as described previously (10). The wet weights of the epididymal, mesenteric, and retroperitoneal fat pads were determined on d 180 and the adiposity index computed as described previously (29).
Statistical analysis. Data were analyzed statistically using SPSS (version 10.0). All values are presented as means ± SEM. Differences between control and Mg-restricted dams and their pups (up to weaning) were analyzed by Students t test. Data from pups were analyzed on d 90 and 180, using one-way ANOVA followed by post-hoc least significant difference (LSD) tests. If heterogeneity was observed in the variance, differences between groups were tested by the nonparametric Mann-Whitney U test.
| RESULTS |
|---|
|
|
|---|
Pups: growth characteristics. Despite comparable birth weights and maintaining a uniform litter size of 8 pups/dam from postnatal day 3, R pups had lower (P < 0.05) weaning weights than control pups (Table 1). R pups weighed less even on d 180, whereas RP and RW pups caught up with controls by d 90 (Table 1). However, BMI did not differ among pups of the 4 groups at either time point (data not shown). As expected, R pups had lower (P < 0.05) plasma Mg concentrations than controls until d 180, whereas RP and RW pups caught up with controls by d 90 and remained at those levels (Table 1).
|
Even on d 180, C and R pups had comparable fasting glucose concentrations, and RW, but not RP pups, had higher (P < 0.05) fasting glucose concentrations than controls (Fig. 2A). However, at this time, R pups had higher (P < 0.05) fasting insulin concentrations than controls and neither rehabilitation regimen mitigated this change (Fig. 2B). On the contrary, RP and RW pups had higher (P < 0.01) fasting insulin concentrations than R pups. As a result, HOMA-IR values computed from fasting glucose and insulin were higher (P < 0.05) in R pups than in controls (Fig. 2C) and rehabilitation from parturition or weaning increased the values further (P < 0.001).
|
On d 180, the glucose AUC did not differ between C and R pups (Fig. 2D). Only RW pups had a higher (P < 0.01) glucose AUC than the other groups. Also, RW pups, but not others, had impaired glucose tolerance. Interestingly, the insulin AUC was lower (P < 0.01) in R pups than in controls, and it was not affected by either rehabilitation regimen (Fig. 2E). As a consequence, the ratio of glucose AUC:insulin AUC was higher (P < 0.01) in R pups than in controls and neither rehabilitation regimen mitigated this change (Fig. 2F).
On d 180, pups in all groups had peak glucose values 30 min after the glucose load. RW pups had higher plasma glucose than controls at 30, 60 (P < 0.001), and 120 min (P < 0.05) (Fig. 3A). On challenge with glucose, control pups showed a robust insulin response by 15 min (compared with their plasma insulin at time 0), which peaked at 30 min and gradually returned to fasting level by 120 min. Fasting insulin concentrations were higher (P < 0.05, 0.01, and 0.001, respectively) in R, RP, and RW pups than controls. However they responded to the glucose load with a moderate increase in insulin, which peaked at 15 min, dropped to the lowest concentrations (markedly lower than their fasting concentrations) by 30 min, and recovered slowly to concentrations higher (P < 0.05) than controls by 120 min. Indeed R, RP, and RW pups had lower (P < 0.001) plasma insulin concentrations than controls at 30 min postglucose load, when glucose concentrations had actually reached their peak (Fig. 3B).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Mg restriction for 9 wk lowered plasma Mg concentrations in female WNIN rats but did not affect their food intake, body weight gain, IR status, plasma glucose, and lipids, probably indicating that they were moderately Mg deficient. This could be a reason for the lack of IR in these rats, unlike earlier studies reporting IR in Mg deficiency (14,17). That Mg restriction had no effect on the dams reproductive performance or the pups birth weight corroborates the above inference and agrees with similar reports (30). However, maternal Mg restriction that continued through lactation and weaning decreased the pups body weight at weaning and thereafter, indicating the importance of neonatal and postnatal Mg nutrition in developing rat pups (31,32). That both the rehabilitation regimens could prevent these changes further corroborates this observation.
In line with earlier reports (9,33) showing unaltered glucose tolerance at 3 mo of age in pups of protein- or iron-restricted rat dams, maternal Mg restriction continued postnatally had no significant effect on pups fasting glucose, insulin, HOMA-IR, and glucose tolerance on d 90. That RW but not RP pups had significantly higher fasting glucose at this time underscores that perinatal Mg nutrition modulates pups glucose tolerance and agrees with our observations in pups of vitamin-restricted rat dams (34).
Altered body adiposity and/or lipid metabolism occurs much before tissues become insulin resistant (3537) and may initiate tissue IR (37,38). In line with the increased body fat and plasma triglycerides we observed earlier in pups of multiple mineral-restricted rat dams (10), R pups had a higher percentage of body fat and plasma triglycerides and lower LBM and FFM than controls on d 90, suggesting their probable predisposal to IR. That the 2 rehabilitation regimens could partly correct these changes suggests that maternal and perinatal Mg restriction may modulate or program the pups body composition and lipid metabolism.
It was interesting that on d 180, R pups had higher fasting plasma insulin and HOMA-IR than controls, emphasizing the importance of maternal and perinatal Mg deficiency in IR development in pups. That neither rehabilitation regimen affected these indices on d 180 not only suggests the importance of maternal Mg deficiency in predisposing pups to fasting hyperinsulinemia and IR but also the irreversibility of the defect. Further, impaired glucose tolerance seen only in RW pups is similar to our finding in vitamin-deficient and rehabilitated pups (34) and stresses that perinatal Mg nutrition is important in modulating glucose tolerance in pups. This view seems to be corroborated by our observation that RP pups had normal glucose tolerance.
These findings are in agreement with our earlier observations in pups of mineral-restricted rat dams (10) and in both studies, pups appeared predisposed to IR. However, a closer comparison of the 2 studies is perplexing. Maternal Mg restriction induced IR, glucose intolerance, and increased body adiposity in pups, whereas multiple mineral restriction increased pups percentage of body fat only by 6 mo of age. Although reasons for these discrepancies are not clear, it appears that the effects of maternal Mg deficiency on some of the variables were countered by the deficiencies of one or more of the other minerals in our earlier study (10). Alternatively, it could also be due to greater restriction of dietary Mg (to 30% of controls) in this study than in the previous one (50% of controls).
Although R pups showed an early insulin response on challenge with glucose load (peaking at 15 min compared with 30 min in controls), peak insulin concentrations were markedly lower than those of controls. Moreover, in R pups, plasma insulin fell drastically below the fasting concentrations by 30 min, when glucose concentrations actually peaked. Together with fasting hyperinsulinemia, lower insulin AUC values in R pups indicate that postnatal continuation of maternal Mg restriction not only induced fasting hyperinsulinemia and IR in R pups but also impaired their insulin response to glucose challenge. That only RW but not RP pups had IR as well as glucose intolerance strongly suggests a significant role for perinatal Mg nutrition in modulating pups glucose metabolism and agrees with similar previous reports (39). Overall, these observations agree with Barkers hypothesis (1,2), are similar to those typical of type 2 diabetic patients (40), and appear to suggest an irreversible exhaustion of ß cells in Mg-restricted pups.
The persistent increase in body adiposity of R pups on d 180 and the inability of either rehabilitation regimen to correct it suggest that the changes were probably programmed during intrauterine growth, persisted throughout life, and were not reversible by rehabilitation from as early as parturition. Further, the significantly higher wet weights of fat deposits, epididymal, retroperitoneal, and mesenteric, in R, RP, and RW pups relative to the controls not only corroborate the TOBEC measurements but also indicate the distribution of increased body fat throughout the abdomen and not specific to any tissue. These findings are consistent with observations in the literature that abdominal adiposity is an important factor in the development of insulin resistance syndrome (37). Also, the high percentage of body fat, low body weight, and decreased LBM and FFM observed in R pups are similar to those reported in "thin fat babies" in India, an abnormal condition attributed to maternal malnutrition (41).
One study (42) reported altered lipid metabolism in pups of rat dams subjected to protein malnutrition or iron deficiency during pregnancy. However, we observed hypertriglyceridemia in R pups on d 90 but not d 180, suggesting that the changes could be transient. Similarly, plasma total cholesterol, which did not differ among pups of the 4 groups on d 90, was significantly lower in R pups on d 180, and both rehabilitation regimens mitigated these changes. Whether the change in total cholesterol is transient and the nature of its role, if any, in the development of IR and/or body composition change in pups remains to be deciphered. However, maternal Mg restriction did not affect plasma HDL cholesterol and FFAs.
The body composition of R pups was altered by d 90, but they did not become insulin resistant until d 180; this agrees with evidence indicating that altered adiposity and/or lipid metabolism is seen much before IR manifests (35,36) and supports the hypothesis that IR originates in impaired adipogenesis and/or lipid metabolism (36,37). From our results, the recent increase in IR and associated diseases among Indians appear to be due in part to the widely prevalent Mg deficiency among pregnant and lactating women (23).
In conclusion, our results indicate that maternal Mg restriction alters body adiposity early in the life of pups. They stress the importance of maternal Mg status in regulating insulin synthesis and/or secretion in pups, their insulin response to a challenge of glucose, and their progressive development of IR. Also, they indicate that perinatal Mg restriction modulates glucose tolerance and/or metabolism in pups, leading to impaired glucose tolerance. Interestingly, the changes appear to be irreversible by rehabilitation either from parturition or weaning.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: AUC, area under the curve; C, control diet throughout; FFM, fat-free mass; HOMA-IR, homeostasis model assessment of insulin resistance; IR, insulin resistance; LBM, lean body mass; R, magnesium restriction throughout; RP, magnesium-restricted mothers rehabilitated from parturition and their pups from weaning; RW, magnesium-restricted pups weaned onto control diet; TOBEC, total body electrical conductivity; WNIN, Wistar/NIN. ![]()
Manuscript received 29 November 2004. Initial review completed 4 February 2005. Revision accepted 7 March 2005.
| LITERATURE CITED |
|---|
|
|
|---|
1. Barker, D. J., Hales, C. N., Fall, C. H., Osmond, C., Phipps, K. & Clark, P. M. (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67.[Medline]
2. Barker, D. J. & Osmond, C. (1986) Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1:1077-1081.[Medline]
3. Lucas, A. (1998) Programming by early nutrition: an experimental approach. J. Nutr. 128:401S-406S.
4. Godfrey, K. M. & Barker, D. J. (2000) Fetal nutrition and adult disease. Am. J. Clin. Nutr. 71:1344S-1352S.
5. Hoet, J. J. & Hanson, M. A. (1999) Intrauterine nutrition: its importance during critical periods for cardiovascular and endocrine development. J. Physiol. 514:617-627.
6. Ozanne, S. E. & Hales, C. N. (1999) The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc. Nutr. Soc. 58:615-619.[Medline]
7. Woodall, S. M., Johnston, B. M., Breier, B. H. & Gluckman, P. D. (1996) Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatr. Res. 40:438-443.[Medline]
8. Langley, S. C. & Jackson, A. A. (1994) Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin. Sci. (Lond). 86:217-222.[Medline]
9. Lewis, R. M., Petry, C. J., Ozanne, S. E. & Hales, C. N. (2001) Effects of maternal iron restriction in the rat on blood pressure, glucose tolerance and serum lipids in the 3-month old offspring. Metabolism 50:562-567.[Medline]
10. Venu, L., Harishankar, N., Krishna, T. P. & Raghunath, M. (2004) Does maternal dietary mineral restriction per se predispose the offspring to insulin resistance?. Eur. J. Endocrinol. 151:287-294.[Abstract]
11. Saris, N. E., Mervaala, E., Karppanen, H., Khawaja, J. A. & Lewenstam, A. (2000) Magnesium: an update on physiological, clinical and analytical aspects. Clin. Chim. Acta 294:1-26.[Medline]
12. Paolisso, G., Scheen, A., DOnofrio, F. & Lefebvre, P. (1990) Magnesium and glucose homeostasis. Diabetologia 33:511-514.[Medline]
13. Garfinkel, D. & Garfinkel, L. (1988) Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium 7:249-261.[Medline]
14. Takaya, J., Higashino, H. & Kobayashi, Y. (2004) Intracellular magnesium and insulin resistance. Magnes. Res. 17:126-136.[Medline]
15. Barbagallo, M., Dominguez, L. J., Galioto, A., Ferlisi, A., Cani, C., Malfa, L., Pineo, A., Busardo, A. & Paolisso, G. (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol. Aspects Med. 24:39-52.[Medline]
16. Garland, H. O (1992) New experimental data on the relationship between diabetes mellitus and magnesium. Magnes. Res. 5:193-202.[Medline]
17. Paolisso, G. & Ravussin, E. (1995) Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 80:1382-1385.[Abstract]
18. Lowney, P., Hannon, T. S. & Baron, A. D. (1995) Magnesium deficiency enhances basal glucose disposal in the rat. Am. J. Physiol. 268:E925-E931.[Medline]
19. Nadler, J. L. & Rude, R. K. (1995) Disorders of magnesium metabolism. Endocrinol. Metab. Clin. N. Am. 24:623-637.[Medline]
20. Paolisso, G., Sgambato, S. & Giuglaiano, D. (1988) Impaired insulin induced erythrocytes magnesium accumulation is correlated to impaired insulin mediated glucose disposal in type 2 diabetic patients. Diabetologia 31:910-915.[Medline]
21. Barbagallo, M., Gupta, R. K., Bardicef, O., Bardicef, M. & Resnik, L. M. (1997) Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. J. Clin. Endocrinol. Metab. 82:1761-1765.
22. Rude, R. K. (1992) Magnesium deficiency and diabetes mellitus: causes and effects. Postgrad. Med. 92:217-224.
23. Pathak, P., Kapoor, S. K., Kapil, U. & Dwiwedi, S. N. (2003) Serum magnesium level among pregnant women in a rural community of Haryana State, India. Eur. J. Clin. Nutr. 57:1504-1506.[Medline]
24. Reeves, P. G. (1997) Components of the AIN-93 diets as improvements in the AIN-76A Diet. J. Nutr. 127:838S-841S.
25. Wills, M. R., Sunderman, F. W. & Savory, J. (1986) Methods for the estimation of serum magnesium in clinical laboratories. Magnesium 5:317-327.[Medline]
26. Matthews, J. N., Altman, D. G., Campbell, M. J. & Royston, P. (1990) Analysis of serial measurements in medical research. Br. Med. J. 300:230-235.
27. Bracco, E. F., Yang, M. U., Segal, K., Hashim, S. A. & Van Itallie, T. B. (1983) A new method for estimation of body composition in the live rat. Proc. Soc. Exp. Biol. Med. 74:143-146.
28. Morbach, C. A. & Brans, Y. W. (1992) Determination of body composition in growing rats by total body electrical conductivity. J. Pediatr. Gastroenterol. Nutr. 14:283-292.[Medline]
29. Taylor, B. A. & Phillips, S. J. (1996) Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics 34:389-398.[Medline]
30. Rayssiguier, Y., Badinand, F. & Kopp, J. (1979) Effects of magnesium deficiency on parturition and uterine involution in the rat. J. Nutr. 109:2117-2125.
31. Kubena, K. S., Edgar, S. E. & Veltmann, J. R. (1988) Growth and development in rats and deficiency of magnesium and pyridoxine. J. Am. Coll. Nutr. 7:317-324.[Abstract]
32. Buck, D. R. & Bales, J. (1983) Maternal dietary magnesium effects on lactation success and on milk yield and composition in the rat. J. Nutr. 113:2421-2431.
33. Langley, S. C., Browne, R. F. & Jackson, A. A. (1994) Altered glucose tolerance in rats exposed to maternal low protein diets in utero. Comp. Biochem. Physiol. Physiol. 109:223-229.[Medline]
34. Venu, L., Harishankar, N., Prasanna Krishna, T. & Raghunath, M. (2004) Maternal dietary vitamin restriction increases body fat content but not insulin resistance in the WNIN rat offspring up to six months of age. Diabetologia 47:1493-1501.[Medline]
35. Yajnik, C. S. (2002) The lifecycle effects of nutrition and body size on adult adiposity, diabetes and cardiovascular disease. Obes. Rev. 3:217-224.[Medline]
36. Smith, U., Axelsen, M., Carvalho, E., Eliasson, B., Jansson, P. A. & Wesslau, C. (1999) Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann. N. Y. Acad. Sci. 892:119-126.[Medline]
37. Smith, U. (2002) Impaired (diabetic) insulin signaling and action occur in fat cells long before glucose intoleranceis insulin resistance initiated in the adipose tissue?. Int. J. Obes. Relat. Metab. Disord. 26:897-904.[Medline]
38. Srinivasan, S. R., Myer, L. & Berenson, G. S. (2002) Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 51:204-209.
39. Gueux, E. & Rayssiguier, Y. (1983) The effect of magnesium deficiency on glucose stimulated insulin secretion in rats. Horm. Metab. Res. 15:594-597.[Medline]
40. Kao, W. H., Folson, A. R., Nieto, F. J., Mo, J. P., Watson, R. L. & Brancati, F. L. (1999) Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch. Intern. Med. 159:2151-2159.
41. Yajnik, C. S., Fall, C. H., Coyaji, K. J., Hirve, S. S., Rao, S., Barker, D. J., Joglekar, C. & Kellingray, S. (2003) Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int. J. Obes. Relat. Metab. Disord. 27:173-180.[Medline]
42. Lucas, A., Baker, B. A., Desai, M. & Hales, C. N. (1996) Nutrition in pregnant or lactating rats programs lipid metabolism in the offspring. Br. J. Nutr. 76:605-612.[Medline]
This article has been cited by other articles:
![]() |
I. J. N. Padmavathi, Y. D. Kishore, L. Venu, M. Ganeshan, N. Harishankar, N. V. Giridharan, and M. Raghunath Prenatal and perinatal zinc restriction: effects on body composition, glucose tolerance and insulin response in rat offspring Exp Physiol, June 1, 2009; 94(6): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||